Many biotechnology companies appear to be taking fewer chances lately -- to the point that the industry seems to have lost its nerve.
More and more start-ups now seem focused on scrounging around ...
"There's a fair question: Where's all the new stuff going on?"
As big pharmaceutical companies have become even larger, they have concentrated on drugs with blockbuster potential rather than devote time to drugs with smaller markets.
[Hmmm ... Where have I heard that story before?]
I bet Norah Jones is popular at biotech firms, both as inspiration and as consolation.
Is Biotechnology Losing Its Nerve?